AITOPAI热报
Industry75°

Isomorphic Labs筹21亿美元加速AI药物研发

Official accountDemis Hassabis@demishassabis
Post
View the post
Why we picked it

这笔融资规模表明AI制药领域的投资热度持续攀升，Isomorphic Labs的技术路径（AI+蛋白质结构预测）可能加速药物研发流程，对生物医药行业具有示范效应。

Isomorphic Labs（由DeepMind创始人Demis Hassabis创立）宣布获得21亿美元新融资，用于利用AI技术重新定义药物发现过程。

Body

该公司此前基于AlphaFold技术，致力于通过AI模型预测蛋白质结构并加速新药开发。这笔巨额投资将推动其“解决所有疾病”的长期目标。

Industry Coordinates & Source Verification

This report is categorized under AITOP's "Industry" desk. Key entities and technical topics under continuous tracking include AI制药, 蛋白质预测, AlphaFold, Isomorphic Labs.

Source attribution: curated from Demis Hassabis (@demishassabis).

#AI制药#蛋白质预测#AlphaFold#Isomorphic Labs#投资融资

Keep reading

Recent stories with the same tag or section
ProductsBuilders13:42
Chinese contentPhaSER Biomedical获盖茨基金会270万美元资助，推进8HUM模型与HERALD AI

药企做临床前毒性筛选的老办法是拿小鼠凑合，人代谢和小鼠代谢差太多，漏掉的毒性到人体试验才暴露。这家苏格兰公司用带人类代谢酶基因的转基因小鼠加HERALD AI来补这个坑，盖茨基金会给了270万美元。做药物研发或关注AI制药的人可以看看。

#PhaSER Biomedical#HERALD AI#8HUM#药物研发
HIT Consultant@Jasmine PennicSource
ModelsBuilders72°07:30
Chinese content谷歌 DeepMind 发布 AlphaGenome 2：深入单细胞层面预测基因变异影响

DeepMind 把基因组预测从组织级别推进到了单细胞级别，致病变异识别率从 16% 提到 30%，还首次支持 DNA 甲基化预测。做遗传学、药物研究的科研人员可以直接用 API 免费跑，不用自己微调模型就能分析新细胞类型。

#AlphaGenome 2#Google DeepMind#基因组学#单细胞分析
IT之家Source
IndustryBuildersMulti-source00:52
Chinese contentDario Amodei 预测癌症、阿尔茨海默病等疾病十年内或被攻克

Anthropic 的 CEO 放话十年内攻克癌症和阿尔茨海默病，正好卡在 IPO 节点前，动机值得琢磨。AI 制药确实在提速，但十年说法业内争议不小。关心 AI 医疗落地和 Anthropic 动向的人可以看看各方怎么看。

#Anthropic#Dario Amodei#AI制药#生物医药
Event
kimmonismus@kimmonismusSource
ProductsBuildersSelected23:27
Google DeepMind releases AlphaGenome 2 for cell-specific disease research

Cell-specific variant interpretation is a bottleneck in translating genome sequencing into clinical insight, and AlphaGenome 2 targets exactly that gap. Genomics labs, computational biologists, and biotech teams evaluating disease-causing mutations can use it to prioritise variants by affected tissue. Compared with AlphaFold, which resolved protein structure, this model moves DeepMind's tooling upstream into gene regulation, a space where competitors like Enformer and Evotec partnerships have been active.

#AlphaGenome#Google DeepMind#genomics#variant interpretation
Official accountGoogle DeepMind@GoogleDeepMindSource